RESULTS	There was no difference in 6-month neurologic outcome among groups with regard to proportions of patients with severe TBI ( GOSE 4 ) ( hypertonic saline/dextran vs normal saline : 53.7 % vs 51.5 % ; difference , 2.2 % [ 95 % CI , -4.5 % to 9.0 % ] ; hypertonic saline vs normal saline : 54.3 % vs 51.5 % ; difference , 2.9 % [ 95 % CI , -4.0 % to 9.7 % ] ; P = .67 ) .\